The EMERGEncy ID NET Study Group
The EMERGEncy ID NET Study Group
批准号:
9269061
负责人:
DAVID ANDREW TALAN
金额:
$40.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2021-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
EMERGEncy ID NET is a sentinel network for surveillance and research of emerging infectious
diseases. It is comprised of 11 high-volume, geographically-diverse, and academically-affiliated
emergency departments in the United States. EMERGEncy ID NET was created in 1995 in
response to the Centers for Disease Control and Prevention's (CDC) strategic plan to enhance
surveillance mechanisms using novel approaches. A CDC cooperative grant has funded the
network for the last 20 years during which EMERGEncy ID NET has studied a wide range of
infections and has been a model for the creation of multi-center, clinical syndrome-based
research networks. The research network has continued to successfully address the threat of
emerging infectious diseases by assessing disease prevalence, risk factors, and management
practices for acute presentations from the community among a diverse population presenting to
emergency departments. Numerous peer-reviewed publications have resulted from
EMERGEncy ID NET research in journals that include The New England Journal of Medicine,
JAMA, Clinical Infectious Diseases, Emerging Infectious Diseases, and Annals of Emergency
Medicine.
The EMERGEncy ID NET program plans to continue collaboration with the CDC to conduct
ongoing investigations of various emerging and prevalent infections in the United States. This
will be accomplished by: 1) identifying emerging and prevalent infections among emergency
department patients; 2) developing study objectives and materials to conduct prospective
studies; 3) obtaining necessary approvals to conduct the research from Human Subject
Protection Committees; 4) implementing studies through enrollment and follow-up of emergency
department patients; 5) managing data collected; 6) generating results from studies and
reporting our findings in peer-reviewed publications and at scientific conferences; and 7)
expanding the network to involve more emergency departments to improve our capability of
generalizing our findings to additional populations in the United States.
The accomplishments of the EMERGEncy ID NET program over the past 20 years demonstrate
its capability to rapidly address a variety of urgent public health infectious disease problems and
propagate the results of investigations effectively to infectious disease, public health,
emergency medicine practitioners, and the public. EMERGEncy ID NET investigators have
several ongoing and new projects planned to address current and anticipated emerging
infection threats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research - 2022
-
批准号:10516881
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:DAVID ANDREW TALAN
-
依托单位:
RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research - 2022
-
批准号:10910857
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2022
-
负责人:DAVID ANDREW TALAN
-
依托单位:
RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research - 2022
-
批准号:10687883
-
项目类别:
-
资助金额:$1361.33万
-
财政年份:2022
-
负责人:DAVID ANDREW TALAN
-
依托单位:
RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research - 2022
-
批准号:10827992
-
项目类别:
-
资助金额:$196.28万
-
财政年份:2022
-
负责人:DAVID ANDREW TALAN
-
依托单位:
The EMERGEncy ID NET Study Group
-
批准号:10155370
-
项目类别:
-
资助金额:$369.05万
-
财政年份:2016
-
负责人:DAVID ANDREW TALAN
-
依托单位:
The EMERGEncy ID NET Study Group
-
批准号:10571702
-
项目类别:
-
资助金额:$95.34万
-
财政年份:2016
-
负责人:DAVID ANDREW TALAN
-
依托单位:
The EMERGEncy ID NET Study Group
-
批准号:9914875
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2016
-
负责人:DAVID ANDREW TALAN
-
依托单位:
The EMERGEncy ID NET Study Group
-
批准号:9203074
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2016
-
负责人:DAVID ANDREW TALAN
-
依托单位:
The EMERGEncy ID NET Study Group
-
批准号:10301347
-
项目类别:
-
资助金额:$488.17万
-
财政年份:2016
-
负责人:DAVID ANDREW TALAN
-
依托单位:
The EMERGEncy ID NET Study Group
-
批准号:10164676
-
项目类别:
-
资助金额:$160.73万
-
财政年份:2016
-
负责人:DAVID ANDREW TALAN
-
依托单位:
Pilot Randomized Trial of Antibiotics vs Surgery for Treating Acute Appendicitis
-
批准号:8823328
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2014
-
负责人:DAVID ANDREW TALAN
-
依托单位:
Pilot Randomized Trial of Antibiotics vs Surgery for Treating Acute Appendicitis
-
批准号:8935768
-
项目类别:
-
资助金额:$12.23万
-
财政年份:2014
-
负责人:DAVID ANDREW TALAN
-
依托单位:
EMERGENCY ID NET STUDY
-
批准号:8528230
-
项目类别:
-
资助金额:$6.73万
-
财政年份:2011
-
负责人:DAVID ANDREW TALAN
-
依托单位:
EMERGENCY ID NET STUDY
-
批准号:8263326
-
项目类别:
-
资助金额:$37.31万
-
财政年份:2011
-
负责人:DAVID ANDREW TALAN
-
依托单位:
EMERGENCY ID NET STUDY
-
批准号:8847567
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2011
-
负责人:DAVID ANDREW TALAN
-
依托单位:
EMERGENCY ID NET STUDY
-
批准号:8490598
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2011
-
负责人:DAVID ANDREW TALAN
-
依托单位:
EMERGENCY ID NET STUDY
-
批准号:8657796
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2011
-
负责人:DAVID ANDREW TALAN
-
依托单位:
EMERGENCY ID NET STUDY
-
批准号:8233796
-
项目类别:
-
资助金额:$37.31万
-
财政年份:2011
-
负责人:DAVID ANDREW TALAN
-
依托单位:
EMERGEncy ID Net Study
-
批准号:7612002
-
项目类别:
-
资助金额:$40.9万
-
财政年份:2006
-
负责人:DAVID ANDREW TALAN
-
依托单位:
EMERGEncy ID Net Study
-
批准号:7240554
-
项目类别:
-
资助金额:$41.76万
-
财政年份:2006
-
负责人:DAVID ANDREW TALAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ID2驱动的生物钟紊乱通过PI3K-AKT信号轴调控前列腺癌细胞异质性和可塑性的研究
-
批准号:JCZRLH202600193
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
Id2在胶质母细胞瘤中的作用及Id2/Oligo2促进胶质母细胞瘤EMT的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:彭灿
-
依托单位:
清肺合剂上调丁酸调控 HDACs/ID2/IL-12R 通
路增强 PD-1 抑制剂抗肺癌作用的机制研究
-
批准号:Q24H290030
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陈卓
-
依托单位:
DRAL-Id3 轴在造血应激状态下调控 HSCs 自
我更新的分子机制研究
-
批准号:Y24H080015
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陈一瑞
-
依托单位:
基于机器学习的学龄期 ASD 儿童合并 ID 的诊
断模型构建及应用研究
-
批准号:TGY24H090015
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:宋超
-
依托单位:
ID3 表达对东方田鼠自发性卵巢癌细胞增殖与凋亡的影响
及作用机制研究
-
批准号:2024JJ6494
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:何天琼
-
依托单位:
印记基因Gnas高甲基化调控卵巢ID1表达介导父体咖啡因暴露致子代卵巢储备降低及其分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
ID2 调 控 IRF5 抑 制 肺 泡 巨 噬 细 胞 M1 极 化 缓 解
ALI/ARDS 进展的机制研究
-
批准号:2024JJ5609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李瑛
-
依托单位:
β2-AR/ID4信号通路介导小胶质细胞抑炎作用在PD中的保护性机制研究
-
批准号:82371252
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘小利
-
依托单位:
转录复合体ID1/YY1驱动有氧糖酵解促进上皮性卵巢癌腹腔转移的机制研究
-
批准号:82303207
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:孟娇
-
依托单位: